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ABSTRACT 1 
Background Severe mental illness (SMI), comprising schizophrenia, bipolar disorder and major depression, 2 
is associated with higher myocardial infarction (MI) mortality but lower coronary revascularisation rates. 3 
Previous studies have largely focused on schizophrenia, with limited information on bipolar disorder and 4 
major depression, long-term mortality or the effects of either sociodemographic factors or year of MI. We 5 
investigated the associations between SMI and MI prognosis and how these differed by age at MI, sex and 6 
year of MI. 7 
Methods We conducted a national retrospective cohort study, including adults with a hospitalised MI in 8 
Scotland between 1991 and 2014. We ascertained previous history of schizophrenia, bipolar disorder and 9 
major depression from psychiatric and general hospital admission records. We used logistic regression to 10 
obtain odds ratios adjusted for sociodemographic factors for 30-day, one-year and five-year mortality, 11 
comparing people with each SMI to a comparison group without a prior hospital record for any mental 12 
health condition. We used Cox regression to analyse coronary revascularisation within 30 days, risk of 13 
further MI and further vascular events (MI or stroke). We investigated associations for interaction with age 14 
at MI, sex and year of MI. 15 
Results Among 235 310 people with MI, 923 (0.4%) had schizophrenia, 642 (0.3%) had bipolar disorder and 16 
6239 (2.7%) had major depression. SMI was associated with higher 30-day, one-year and five-year mortality 17 
and risk of further MI and stroke. Thirty-day mortality was higher for schizophrenia (OR 1.95, 95% CI 1.64–18 
2.30), bipolar disorder (OR 1.53, 95% CI 1.26–1.86) and major depression (OR 1.31, 95% CI 1.23–1.40). Odds 19 
ratios for one-year and five-year mortality were larger for all three conditions. Revascularisation rates were 20 
lower in schizophrenia (HR 0.57, 95% CI 0.48–0.67), bipolar disorder (HR 0.69, 95% CI 0.56–0.85) and major 21 
depression (HR 0.78, 95% CI 0.73–0.83). Mortality and revascularisation disparities persisted from 1991 to 22 
2014, with absolute mortality disparities more apparent for MIs that occurred around 70 years of age, the 23 
overall mean age of MI. Women with major depression had a greater reduction in revascularisation than 24 
men with major depression. 25 
Conclusions There are sustained SMI disparities in MI intervention and prognosis. There is an urgent need 26 
to understand and tackle the reasons for these disparities. 27 
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BACKGROUND 3 
Cardiovascular disease (CVD) is a major contributor to the marked premature mortality in people with 4 
severe mental illness (SMI), including schizophrenia, bipolar disorder and major depression [1-5]. There has 5 
been considerable research on the impact of SMI on CVD occurrence, but far less on the effect on CVD 6 
outcomes. Over the past twenty years, accumulating evidence suggests that people with SMI have poorer 7 
outcomes following a myocardial infarction (MI) [6-8] and are less likely to receive coronary 8 
revascularisation than those without mental illness [7, 9-12]. However, most studies have examined the 9 
effect of schizophrenia on MI outcomes [8, 11], with far less investigation of the effect of prior bipolar 10 
disorder [6, 7, 9, 13] or major depression [7, 10]. Effects of SMI on longer term mortality (beyond one-year 11 
post-MI) have rarely been studied [14], no study (to our knowledge) has specifically assessed further MI, 12 
and there are limited data on whether associations differ by age at MI and sex. The relative risk of mortality 13 
in younger people with schizophrenia may be lower than in older people [6], whilst women with SMI may 14 
be treated more conservatively than men with the same illness [7]. 15 
It is unclear whether disparities in mortality and revascularisation are changing over time. The MI mortality 16 
gap for schizophrenia compared to the general population may have widened between 1995 and 2015 in 17 
Denmark [14], whilst mental health disparities in revascularisation rates do not appear to be narrowing in 18 
the USA [9, 10]. To our knowledge, no study has reported trends in coronary revascularisation following MI 19 
by year of MI and SMI status in a universal healthcare setting. 20 
We therefore conducted a retrospective cohort study to investigate the effect of a previous diagnosis of 21 
schizophrenia, bipolar disorder and major depression on risks of mortality, further MI and other vascular 22 
events, and rates of revascularisation following hospital admission for MI, by year of MI, age at MI and sex. 23 
We analysed SMI conditions separately to achieve greater epidemiological insight across these disorders. 24 
Whilst they share some commonalities in the pattern of association with physical disease, it may be 25 
inappropriate to assume they are homogeneous with respect to patterns of physical disease outcomes and 26 
receipt of clinical care. 27 
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METHODS 1 
This study is reported in accordance with the Standard Reporting of Observational Studies in Epidemiology 2 
(STROBE) [15] and Reporting of Studies Conducted using Observational Routinely Collected Health Data 3 
(RECORD) [16] statements. 4 
Study population 5 
We identified all adults aged 18 and over with a diagnosis of MI recorded in the Scottish Morbidity Record 6 
General/Acute Inpatient and Day Case dataset (SMR01, see https://www.ndc.scot.nhs.uk/Data-7 
Dictionary/SMR-Datasets/SMR01-General-Acute-Inpatient-and-Day-Case/) between 1 January 1991 and 31 8 
December 2014. SMR01 includes details of all acute hospital admissions in Scotland from 1980 onwards 9 
and information on clinical procedures/interventions coded using the fourth revision of the OPCS 10 
Classification of Interventions and Procedures (OPCS-4). We identified incident MIs using the ninth and 11 
tenth revisions of the International Classification of Diseases (ICD9 410 and ICD10 I21 and I22), where codes 12 
were included in a primary or secondary diagnosis field. We defined incident events as MIs that occurred 13 
between 1 January 1991 and 31 December 2014, where no previous admissions to hospital for MI had been 14 
recorded during the preceding 10 years. 15 
Definition and ascertainment of SMI 16 
We determined history of a mental health condition from the Scottish Mental Health Inpatient and Day 17 
Case (SMR04) dataset (which records psychiatric hospital admissions from 1981 onward) and the SMR01 18 
dataset. We identified mental health conditions from primary or secondary diagnosis fields of admissions 19 
that occurred after the individual’s 18th birthday and before their incident MI (Additional file 1: Table S1) 20 
[17, 18]. We categorised people into three mutually exclusive SMI groups. Where individuals had a record 21 
of more than one diagnosis, we used a severity hierarchy, with schizophrenia considered the most severe, 22 
followed by bipolar disorder and major depression. We compared MI outcomes in people with a history of 23 
each of these three disorders to those with no prior hospital record for any mental health condition. 24 
Outcomes 25 
Primary outcomes were 30-day and one-year mortality and coronary revascularisation. Secondary 26 
outcomes included five-year mortality, mortality over the entire follow-up period, time to further MI and 27 
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time to further vascular event (fatal or non-fatal MI or stroke). We identified deaths up to 31 December 1 
2018 from Scottish death records which include date and cause of death, as recorded on the death 2 
certificate. The analysis of five-year mortality includes a smaller cohort of MI admissions up to 2013 so that 3 
all individuals potentially have at least five years of follow-up. For mortality over the entire follow-up 4 
period, time to death was calculated from the date of the incident MI to the date of death, with follow-up 5 
to the end of 2018.  We identified the following coronary revascularisation procedures from OPCS-4 codes 6 
recorded in SMR01 (Additional file 1: Table S2) [19]: percutaneous transluminal coronary angioplasty 7 
(PTCA); percutaneous coronary intervention (PCI); and coronary artery bypass graft (CABG). We 8 
investigated coronary revascularisation within 30 days in line with the time frame used in previous studies 9 
of revascularisation following MI.  Time to revascularisation was calculated from the date of the incident MI 10 
to the date of the first subsequent revascularisation procedure, regardless of whether the individual 11 
experienced another MI. We identified further events (occurring more than 30 days after the index MI) 12 
from SMR01 and death records based on conditions recorded in primary or secondary fields. We identified 13 
further MI using the same ICD-9 and ICD-10 codes as for the index MI and stroke using ICD-9 codes 430, 14 
431, 434 and 436 and ICD-10 codes I60, I61, I63 and I64. Time to further MI and time to further vascular 15 
event were each calculated from the date of the incident MI to the date of the next MI or vascular event, as 16 
appropriate, regardless of whether revascularisation was received.  17 
Sociodemographic and clinical covariates 18 
Area-based deprivation, urbanicity and NHS health board (with Scotland divided into 14 regional areas for 19 
the purposes of healthcare delivery) were defined based on each person’s place of residence at the time of 20 
MI. Area-based deprivation was measured by the Carstairs Index in line with recommendations for the 21 
analysis of deprivation in Scotland where the time frame starts prior to 1996 [20]. The Carstairs Index is 22 
based on four census variables (car ownership, male unemployment, household overcrowding and low 23 
occupational social class), calculated at the postcode sector level and divided into quintiles based on the 24 
entire Scottish population (Additional file 1: Text S1) [20-22]. Urbanicity was classified according to the 25 
Scottish Government six-fold urban rural indicator [23]. We ascertained history of alcohol use disorder 26 
based on all hospital records before the date of first MI and defined it using ICD codes for mental and 27 
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behavioural disorders due to alcohol use and physical health conditions caused by alcohol use disorder (as 1 
listed in Additional file 1: Table S3). For each MI, we used ICD codes to identify diagnoses of diabetes, 2 
chronic obstructive pulmonary disease (COPD) and heart failure from the hospital discharge record for the 3 
index MI (Additional file 1: Table S4). 4 
Statistical analyses 5 
We used direct standardisation to calculate sex-specific age-standardised rates for the three primary 6 
outcomes, by age at MI and year of MI group. We used only four age groups (<60, 60-69, 70-79 and ≥80 7 
years) and four year groups of equal duration to ensure that there were sufficient numbers within each 8 
group for the standardisation. We derived sex-specific age distributions for the standard population from 9 
the distributions observed in the period 2003-2008.  10 
We used logistic regression to model 30-day, one-year and five-year mortality, and Cox proportional 11 
hazards regression for coronary revascularisation, mortality during the entire follow-up period and for time 12 
to further events. For coronary revascularisation and time to further events, we accounted for death as a 13 
competing risk, censoring at the date of death. To evaluate coronary rescularisation within 30 days, we also 14 
censored individuals alive at 30 days at this time point. We included age at MI and year of MI as continuous 15 
variables modelled as fractional polynomials in order to allow for non-linear relationships between these 16 
variables and the outcomes [24], and the remaining covariates as categorical variables. For each outcome, 17 
model 1 included SMI, age at MI, sex and year of MI, while model 2 additionally included history of alcohol 18 
use disorder, deprivation, urbanicity, and health board. To investigate whether associations between SMI 19 
and each of the outcomes varied by age at MI, sex and year of MI model 3 also included two-way 20 
interaction terms between mental health condition and each of these variables. Based on model 3, we used 21 
analysis of deviance to evaluate the statistical significance of the interactions and plotted odds ratios (or 22 
hazard ratios) by year of MI and sex for people with MI at different ages. We also developed a Shiny app to 23 
display additional interactive plots of trends by year of MI and age at MI (https://uiphsi-24 
mdcvddm.shinyapps.io/mi-outcomes-mmd/). Among those who survived more than 30 days we fitted a 25 
fourth model for analyses of mortality and further events, adjusting for receipt of revascularisation within 26 
30 days. 27 
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In sensitivity analyses we redefined major depression based on psychiatric hospital admission records only 1 
and identified coronary revascularisation within 90-days of MI. We used R version 3.6.1 for all analyses [25].  2 
RESULTS 3 
Cohort characteristics 4 
We identified 243 091 people with a first-ever MI between 1991 and 2014. After exclusions, we included 5 
235 310 in our study cohort (see flow chart in Additional file 1: Fig. S1). Of these, 923 (0.4%), 642 (0.3%) and 6 
6239 (2.7%) had a hospital admission record of schizophrenia, bipolar disorder and major depression, 7 
respectively. The prevalence of each SMI was higher in 2014 than in 1991 (0.6% versus 0.2% for 8 
schizophrenia, 0.4% versus 0.2% for bipolar disorder and 3.9% versus 1.7% for depression), which partly 9 
reflects a longer look-back period for hospital recording of SMI in people whose MI occurred in later years 10 
of the study period. Comparison of SMI prevalence using the minimum 10-year look-back period for all MI 11 
patients still revealed an increased prevalence of each SMI in later years, suggesting that improved 12 
diagnosis of SMI over time and better recording of SMI in general hospital admission records might also 13 
play a role. Almost 60% of the cohort were male. There were more men than women in the group with 14 
schizophrenia, but more women among those with bipolar disorder and major depression (Table 1). MI 15 
occurred at a younger age in people with schizophrenia and bipolar disorder (62 and 68 years respectively) 16 
than those with no mental health condition (69 years). Compared to those with no mental illness, people 17 
with each psychiatric disorder tended to be of a lower socioeconomic status, more likely to have an alcohol 18 
use disorder and more likely to have diabetes, COPD and heart failure recorded in their MI admission 19 
record. The median follow-up time was 5.3 years (inter-quartile range 0.4 to 11.6). Overall, 30-day and one-20 
year mortality were 19.7% and 29.7% respectively and 16.4% received coronary revascularisation within 30 21 
days (Table 1, Additional file 1: Tables S5 and S6). [INSERT TABLE 1 HERE] 22 
Absolute rates of mortality and coronary revascularisation by time period 23 
In general, absolute age-standardised sex-specific proportions of 30-day and 1-year mortality were higher 24 
in the groups with a SMI identified from hospital records than in the comparison population with no such 25 
record, and declined between 1991 and 2014 in all groups (Figure 1). However, smaller numbers of people 26 
with schizophrenia and bipolar disorder introduces a greater degree of uncertainty in the pattern of change 27 
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over time for these conditions. Whilst the absolute proportion of coronary revascularisation within 30 days 1 
increased over time in all comparison groups, rates remained much lower in people with each psychiatric 2 
disorder than in the comparison group. 3 
Relative effect of SMI on MI outcomes and coronary revascularisation 4 
After adjusting for age at MI, year of MI and sex, having a prior hospitalisation record for each of 5 
schizophrenia, bipolar disorder and major depression was associated with statistically significant higher 6 
risks of mortality and further events, but lower rates of coronary revascularisation. These associations 7 
attenuated slightly after additional adjustment for alcohol use disorder, deprivation, urbanicity, and health 8 
board (Table 2; model 2). The odds of 30-day mortality were higher in people with schizophrenia, (OR 1.95, 9 
95% CI 1.64–2.30), bipolar disorder (OR 1.53, 95% CI 1.26–1.86) and depression (OR 1.31, 95% CI 1.23–10 
1.40), respectively, compared to the group with no hospital record of a mental health condition. There 11 
were larger differences in one-year and five-year mortality (Table 2). Among those who survived the first 30 12 
days post-MI, a prior history of each SMI was associated with increased odds of over a third of further MI 13 
and further vascular events (Table 2). All three disorders were associated with a substantially reduced rate 14 
of coronary revascularisation within 30 days, which was most marked for schizophrenia (HR 0.57, 95% CI 15 
0.48–0.67; Table 2). Sensitivity analyses for each of the outcomes gave similar results (Additional file 1: 16 
Table S7). [INSERT TABLE 2 HERE] 17 
Interaction between SMI and year of MI, sex and age at MI  18 
From 1991 to 2014, there was no clear change in the odds ratios for 30-day, one-year and five-year 19 
mortality (Figures 2-3, Additional file 1: Table S8 and Fig. S2). However, survival analysis for the whole 20 
follow-up period (which has more statistical power than logistic regression), suggested that for MIs that 21 
occurred in later years there was a widening of the disparity between people with a hospitalisation record 22 
of major depression and those with no hospital record for any mental health condition (Additional file 1: 23 
Table S8 and Fig. S3). For MIs occurring at age 70 (approximately the mean age at first MI) the hazard ratio 24 
for death during follow-up for individuals with major depression versus those without a mental health 25 
condition increased from 1.01 (95% CI 0.81–1.26) for MIs in 1991 to 1.43 (95% CI 1.29–1.58) for MIs in 2014 26 
in women and from 1.07 (95% CI 0.86–1.34) to 1.52 (95% CI 1.37–1.69) in men. We observed a similar 27 
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relative percentage increase in the hazard ratios for other ages. The results for people with schizophrenia 1 
and bipolar disorder were uncertain, with wide confidence intervals, due to smaller numbers of people in 2 
these groups.  There was no evidence of a change from 1991 to 2014 in the association between SMI and 3 
revascularisation (Figure 4, Additional file 1: Table S8 and Fig. S6). Again, results for people with 4 
schizophrenia and bipolar disorder were uncertain. 5 
There was no statistically significant interaction between SMI and sex for the mortality outcomes, but the 6 
reduction in revascularisation among those with major depression was greater for women than men 7 
(Figure 4 and Additional file 1: Fig. S6). There was interaction between age at MI and SMI, for 30-day and 8 
one-year mortality, mortality over the whole follow-up period and revascularisation (Additional file 1: Table 9 
S8, Shiny app). Absolute differences in mortality outcomes between those with and without SMI were 10 
generally greatest for MIs occurring between 60 and 80 years of age and smallest among younger ages.  11 
Finally, among those surviving 30-days, adjusting for receipt of coronary revascularisation had minimal 12 
impact on the associations of SMI with mortality and further events. 13 
DISCUSSION 14 
For people with a MI, having a prior hospitalisation record of schizophrenia, bipolar disorder or major 15 
depression was associated with increased risk of dying in the short- and long-term, and having a further MI 16 
or another vascular event. People with a SMI were far less likely to receive coronary revascularisation; 17 
among those with pre-existing major depression this effect was more marked in women than men. SMI 18 
disparities in both risks of death and receipt of revascularisation did not improve over the period from 1991 19 
to 2014. 20 
Our study benefits from several strengths. It is one of the largest to examine the effect of SMI on MI 21 
outcomes, and coronary revascularisation treatment. Our national cohort was representative of people 22 
admitted to hospital with an MI. We included people with bipolar disorder and major depression, who have 23 
previously been little studied in this context, as well as those with schizophrenia. Including only people with 24 
a hospital record of schizophrenia, bipolar disorder or depression identified individuals at the more severe 25 
end of the mental illness spectrum. Scotland has a universal healthcare system and so our findings are 26 
unbiased by inequalities in access to care based on health insurance provision. The long period of data 27 
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collection facilitated analysis of time-trends in associations with mortality and revascularisation, which have 1 
previously been little studied. Moreover, we also investigated interaction by age at MI and sex.  2 
Since we ascertained prior SMI from general and psychiatric hospital admission data our findings may not 3 
be generalizable to people with a SMI for which they have never been admitted to hospital. There may 4 
have been selection bias in that people with less severe depression may have been included in the 5 
depression group because they were admitted to a general hospital for an unrelated disease. Reassuringly, 6 
sensitivity analyses where we defined depression based on psychiatric hospital admissions only gave very 7 
similar effect estimates. Unfortunately we did not have information on date of onset, or clinical diagnosis, 8 
of SMI (which may have occurred prior to the hospital admission record used to ascertain presence of SMI) 9 
and so could not investigate the effect of duration of mental illness on MI prognosis. Lack of appropriate 10 
data meant that we were unable to account for potential confounding by lifestyle factors (other than 11 
alcohol use disorders), such as smoking, diet or physical exercise, or key comorbidities prior to hospital 12 
admission with MI. Interestingly, adjustment for these in previous studies did not appear to influence the 13 
effect of SMI on mortality and revascularisation [7, 9, 10, 12, 14]. The main focus of our study was on MI 14 
prognosis in terms of death, irrespective of cause, occurring at key clinical time points, and so comparison 15 
of death from specific causes, including CVD, was beyond the scope of this study. Similarly, whilst we 16 
explored whether differences in receipt of timely revascularisation partly explained observed disparities in 17 
outcomes, it was beyond the remit of this study to investigate more broadly the contribution of coronary 18 
revascularisation at any time point to these disparities.  19 
The prevalence of each SMI condition among people hospitalised for MI in our study is highly consistent 20 
with that reported in a previous study that used a similar method of ascertaining SMI comorbidity [6]. The 21 
increased risks of short-term mortality among people with schizophrenia in our study are consistent with 22 
findings in most previous studies [6, 7, 9, 12, 14, 26-28]. One study reported no difference in 30-day 23 
mortality between those with and without schizophrenia, but included far fewer people with schizophrenia 24 
than in our study [29]. The similarly increased risks of 30-day and 1-year mortality among people with 25 
bipolar disorder in our study is consistent with findings from a Swedish study [6]. However, our findings on 26 
short-term mortality in those with both bipolar disorder and depression are not in keeping with other 27 
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studies, which report either no difference in [7, 9, 12], or a reduced risk of [10] mortality in the former 1 
groups. However, potential limitations of these studies include reduced statistical power due to smaller 2 
numbers of patients with bipolar disorder [13] and reliance on MI admission records to determine history 3 
of SMI potentially leading to under-ascertainment of history of bipolar disorder and depression [7, 9, 10]. 4 
We are aware of just one other study examining long-term prognosis after MI in the context of SMI, which 5 
also found that schizophrenia was associated with a marked increase in long-term mortality [14]. Our 6 
finding of interaction by age, but not sex, aligns with findings from Bodén et al. [6]. The lack of interaction 7 
by sex on in-hospital mortality among those with major depression concurs with post-hoc findings from 8 
Schulman-Marcus et al. [10], but not with those from Mohammed et al., who reported a greater effect of 9 
depression (but not schizophrenia or bipolar disorder) on in-hospital MI mortality among men than women 10 
[7]. Comparison of our findings on risk of further events with previous studies is difficult, since these have 11 
either included further events within a composite outcome or analysed these as in-hospital complications 12 
only.  13 
The magnitude of the effect of schizophrenia on receipt of coronary revascularisation in our study is in 14 
keeping with that reported in other studies similarly unselected for age [7, 9, 12, 27, 28]. Two previous 15 
studies similarly reported lower revascularisation rates among those with bipolar disorder [12] and 16 
depression [10]. As observed in our study, women in general are less likely than men to receive coronary 17 
revascularisation, with two studies also reporting that this was more marked among people with 18 
depression [7, 10]. The reasons for the latter observation are unclear and worthy of further investigation.  19 
Despite advances in primary and secondary prevention of MI and overall improvement in MI mortality over 20 
time, our study reveals persistent SMI disparities in MI prognosis and coronary revascularisation over time 21 
in Scotland. A nationwide Danish study reported a widening of the gap in MI mortality between those with 22 
and without schizophrenia during a similar period as in our study [14]. Two US-based studies reported that 23 
the gap in revascularisation rates between those with and without these three psychiatric disorders 24 
persisted between 2002 and 2013 [9, 10]. Similarly, a recent Danish study reported no change over time in 25 
the association between schizophrenia and lower revascularisation rates among people with acute 26 
coronary syndrome (encompassing both MI and unstable angina) [30]. 27 
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The reasons for poorer MI outcomes among people with a SMI remain unclear. The excess risks of mortality 1 
in the short- and long-term, and of further events in our study support a multifactorial explanation. Poorer 2 
lifestyle and comorbidity profiles in people with SMI do not appear to account for the increased mortality 3 
risk, and neither does MI severity [7, 9, 10, 12, 14]. Differences in acute intervention strategies could reflect 4 
reduced patient advocacy and capacity for procedural consent in those with psychiatric illness, and 5 
physician concerns about compliance with medication and regular follow-up, and assumptions about 6 
lifestyle behaviour change. People with schizophrenia may be less likely to be offered investigation and 7 
treatment for MI and more likely to decline investigation and treatment [31]. However robust qualitative 8 
studies are needed to identify patient- and physician-specific factors that may be contributing to the sub-9 
optimal care of these vulnerable groups. Adjustment for receipt of coronary interventions only slightly 10 
attenuated mortality estimates in our study and in others [6, 13, 28], and poorer outcomes are still 11 
observed in those with psychiatric illness where the study population includes only those receiving 12 
coronary revascularisation [32].  13 
Differences in prescription of and adherence to pharmacological and lifestyle approaches to secondary 14 
prevention (critical to reducing MI mortality) could partly explain the apparent poorer effect of coronary 15 
revascularisation on outcomes and the increased risk of further events in those with SMI. A recent novel 16 
study comparing secondary prevention treatment reported higher mortality among untreated patients with 17 
schizophrenia compared to the treated general population, but no difference in mortality among those 18 
treated with any combination of triple therapy drugs [33]. Further study of this and other aspects of the MI 19 
care pathway in relation to psychiatric illness status is needed. Time from symptom onset to hospital arrival 20 
(onset-to-door) and from arrival to revascularisation (door-to-balloon) have been linked to 1-year mortality 21 
[34] and could differ by mental illness status. Cardiac rehabilitation is associated with reduced MI mortality, 22 
but multiple barriers, including low referral rates of patients from low socioeconomic groups and low 23 
participation due to psychological well-being [35] place people with SMI at a disadvantage in terms of 24 
accessing this. Finally, some antipsychotic and anti-depressant drugs prolong the Q-T interval [36] (an 25 
independent predictor of MI mortality [37]) and polypharmacy may augment this risk [38]. 26 
CONCLUSIONS 27 
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We found sustained SMI disparities in MI intervention and prognosis. There is an urgent need to 1 
understand and tackle the reasons for these disparities. Meanwhile, cardiologists and general 2 
practitioners/family physicians should be acutely aware of the potential for under-treatment of MI patients 3 
who have a pre-existing SMI and ensure that clinical decision-making is not inappropriately influenced by 4 
these comorbidities. Improved inter-specialty collaboration, particularly between cardiologists and 5 
psychiatrists, and including effective communication with primary care, could help minimise inequalities in 6 
clinical care and ultimately contribute to improved clinical outcomes for people with SMI.    7 
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TABLES 
Table 1: Baseline characteristics and outcomes of patients with MI, by history of mental health 
admission 
 
No mental 
health 
admission 
(N=227 506) 
Schizophrenia 
(N=923) 
Bipolar disorder 
(N=642) 
Depression 
(N=6239) 
Median follow-up time (IQR), years 5.4 (0.4, 11.7) 4.3 (0.2, 8.9) 3.2 (0.1, 8.6) 3.2 (0.1, 8.0) 
Sex, n (%)     
   Female 93 813 (41.2%) 369 (40.0%) 347 (54.0%) 3555 (57.0%) 
   Male 133 693 (58.8%) 554 (60.0%) 295 (46.0%) 2684 (43.0%) 
Mean age at MI (SD), years 69.1 (13.2) 62.3 (13.5) 67.5 (12.7) 68.9 (13.8) 
Year of MI admission, n (%)     
   1991 - 1995 60 050 (26.4%) 165 (17.9%) 121 (18.8%) 1020 (16.3%) 
   1996 - 2000 48 701 (21.4%) 168 (18.2%) 106 (16.5%) 1067 (17.1%) 
   2001 - 2005 44 426 (19.5%) 196 (21.2%) 161 (25.1%) 1278 (20.5%) 
   2006 - 2010 39 507 (17.4%) 184 (19.9%) 135 (21.0%) 1461 (23.4%) 
   2011 - 2014 34 822 (15.3%) 210 (22.8%) 119 (18.5%) 1413 (22.6%) 
Deprivation quintile, n (%)     
   1 (most deprived) 50 898 (22.4%) 279 (30.2%) 156 (24.3%) 1609 (25.8%) 
   2 47 691 (21.0%) 195 (21.1%) 133 (20.7%) 1345 (21.6%) 
   3 45 792 (20.1%) 188 (20.4%) 106 (16.5%) 1213 (19.4%) 
   4 44 557 (19.6%) 163 (17.7%) 125 (19.5%) 1131 (18.1%) 
   5 (least deprived) 38 568 (17.0%) 98 (10.6%) 122 (19.0%) 941 (15.1%) 
Urbanicity, n (%)     
   Large urban area 78 299 (34.4%) 365 (39.5%) 271 (42.2%) 2408 (38.6%) 
   Other urban area 80 536 (35.4%) 354 (38.4%) 203 (31.6%) 2064 (33.1%) 
   Accessible small town 20 597 (9.1%) 53 (5.7%) 49 (7.6%) 527 (8.4%) 
   Remote small town 9415 (4.1%) 28 (3.0%) 29 (4.5%) 291 (4.7%) 
   Accessible rural 23 960 (10.5%) 84 (9.1%) 56 (8.7%) 532 (8.5%) 
   Remote rural 14 699 (6.5%) 39 (4.2%) 34 (5.3%) 417 (6.7%) 
History of alcohol use disorder, n (%) 5177 (2.3%) 138 (15.0%) 70 (10.9%) 915 (14.7%) 
Diabetes recorded at MI admission, n (%) 22 449 (9.9%) 115 (12.5%) 74 (11.5%) 772 (12.4%) 
COPD recorded at MI admission, n (%) 12 523 (5.5%) 77 (8.3%) 45 (7.0%) 659 (10.6%) 
Heart failure at MI admission, n (%) 37 796 (16.6%) 171 (18.5%) 110 (17.1%) 1067 (17.1%) 
30-day mortality, n (%) 44 580 (19.6%) 203 (22.0%) 154 (24.0%) 1443 (23.1%) 
1-year mortality, n (%) 66 977 (29.4%) 309 (33.5%) 247 (38.5%) 2306 (37.0%) 
Revascularisation within 30 days*     
   Any, n (%) 37 375 (16.4%) 137 (14.8%) 94 (14.6%) 1036 (16.6%) 
   CABG, n (%) 3175 (1.4%) 7 (0.8%) 8 (1.2%) 56 (0.9%) 
   PTCA, n (%) 8219 (3.6%) 30 (3.3%) 22 (3.4%) 193 (3.1%) 
   PCI, n (%) 26 450 (11.6%) 104 (11.3%) 65 (10.1%) 805 (12.9%) 
5-year mortality†     
   N 219 161 868 611 5897 
   n (%) 100 560 (45.9%) 457 (52.6%) 350 (57.3%) 3388 (57.5%) 
CABG=coronary artery bypass graft. COPD=chronic obstructive pulmonary disease. PCI=percutaneous coronary 
intervention. PTCA=percutaneous transluminal coronary angioplasty. *Individuals may have received more 
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than one type of revascularisation operation. †Based on the 225,730 individuals with their first MI between 
1991 and 2013.  
17 
 
Table 2: Effect estimates for MI outcomes in people with versus without a prior mental health admission  1 
Outcome N Model Schizophrenia Bipolar disorder Depression 
30-day mortality, OR (95% CI) 235 310 Model 1 2.06 (1.74, 2.44) 1.58 (1.30, 1.91) 1.37 (1.29, 1.46) 
 
 Model 2 1.95 (1.64, 2.30) 1.53 (1.26, 1.86) 1.31 (1.23, 1.40) 
1-year mortality, OR (95% CI) 235 310 Model 1 2.41 (2.07, 2.81) 1.99 (1.66, 2.37) 1.65 (1.55, 1.75) 
 
 Model 2 2.22 (1.91, 2.59) 1.90 (1.59, 2.27) 1.53 (1.45, 1.63) 
5-year mortality, OR (95% CI) 226 537*
 
Model 1 3.11 (2.67, 3.63) 2.28 (1.89, 2.75) 2.08 (1.96, 2.22) 
  Model 2 2.75 (2.35, 3.20) 2.15 (1.78, 2.59) 1.82 (1.71, 1.94) 
Mortality during follow-up, HR (95% CI) 235 310 Model 1 1.97 (1.82, 2.12) 1.63 (1.50, 1.79) 1.44 (1.40, 1.49) 
 
 Model 2 1.82 (1.68, 1.96) 1.55 (1.42, 1.70) 1.35 (1.31, 1.39) 
Time to further MI, HR (95% CI) 188 930†
 
Model 1 1.50 (1.31, 1.72) 1.38 (1.17, 1.63) 1.45 (1.38, 1.53) 
 
 Model 2 1.42 (1.24, 1.63) 1.34 (1.13, 1.58) 1.38 (1.31, 1.45) 
Time to further vascular event, HR (95% CI) 188 930† Model 1 1.55 (1.37, 1.75) 1.45 (1.25, 1.68) 1.48 (1.41, 1.55) 
 
 Model 2 1.46 (1.29, 1.65) 1.40 (1.20, 1.62) 1.40 (1.33, 1.46) 
Revascularisation within 30 days, HR (95% CI) 235 310 Model 1 0.52 (0.44, 0.62) 0.66 (0.54, 0.80) 0.71 (0.67, 0.76) 
  Model 2 0.57 (0.48, 0.67) 0.69 (0.56, 0.85) 0.78 (0.73, 0.83) 
Model 1 is adjusted for age at MI, sex and year of MI. Model 2 is adjusted for age at MI, sex, year of MI, history of alcohol use disorder, deprivation, urbanicity and health 2 
board. HR=Hazard ratio. OR=Odds ratio. *Myocardial infarction admissions up to 2013 in order to ensure that all individuals have at least 5 years’ follow-up. †Individuals 3 
who survived more than 30 days after MI.  4 
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FIGURE LEGENDS 
Figure 1 Age-standardised rates of the primary outcomes. 
Age-standardised rates of 30-day mortality, 1-year mortality and coronary revascularisation within 30 days following a 
myocardial infarction, by previous hospitalisation with severe mental illness, 1991 – 2014. Shading represents 95% 
confidence intervals 
 
Figure 2 Odds ratios for 30-day mortality comparing people with a hospital record for each SMI 
versus no record of any mental health condition. 
Sex-specific odds ratios and 95% confidence intervals for 30-day mortality following a myocardial infarction, among 70-year 
olds, comparing people with a prior hospital record for each SMI versus no prior record of any mental health condition, 
1991 – 2014. Estimates were obtained from a logistic regression model adjusting for age at MI, year of MI, sex, deprivation, 
urbanity, health board and history of an alcohol use disorder, and including interactions between SMI and each of age at 
MI, year of MI and sex. Shading represents 95% confidence intervals 
 
Figure 3 Odds ratios for 1-year mortality comparing people with a hospital record for each SMI 
versus no record of any mental health condition. 
Sex-specific odds ratios and 95% confidence intervals for 1-year mortality following a myocardial infarction, among 70-year 
olds, comparing people with a prior hospital record for each SMI versus no prior record of any mental health condition, 
1991 – 2014. Estimates were obtained from a logistic regression model adjusting for age at MI, year of MI, sex, deprivation, 
urbanity, health board and history of an alcohol use disorder, and including interactions between SMI and each of age at 
MI, year of MI and sex. Shading represents 95% confidence intervals 
 
Figure 4 Hazard ratios for revascularisation comparing people with a hospital record for each SMI 
versus no record of any mental health condition.  
Sex-specific hazard ratios and 95% confidence intervals for revascularisation within 30 days following a myocardial 
infarction, among 70-year olds, comparing people with a prior hospital record for each SMI versus no prior record of any 
mental health condition, 1991 – 2014. Estimates were obtained from a Cox proportional hazards model adjusting for age at 
MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol use disorder, and including interactions 
between SMI and each of age at MI, year of MI and sex. Shading represents 95% confidence intervals  
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Table S1: ICD-9 and ICD-10 codes used to identify mental health conditions 
 
Mental health condition
1 ICD10 codes
a 
(first 3 digits) 
ICD9 codes
b 
(first 4 digits) 
Schizophrenia: schizophrenia and schizoaffective disorders F20, F25 295.0-295.3, 
295.6-295.9 
Other psychoses: schizotypal disorders, acute and transient 
psychosis, delusional disorders, and other psychotic disorders 
F21-F24, 
F28, F29 
295.4, 295.5, 
297.0-297.9 
298.3, 298.4, 
298.8, 298.9   
Bipolar disorder: manic episode or bipolar affective disorder F30-F31 296.0 
296.2-296.6 
Depression: depressive episode or recurrent depressive disorder F32-F33 296.1 
298.0, 300.4,  311 
Other mental health conditions: including other mood disorders, 
neuroses, dissociative disorders, somatoform disorders, eating 
disorders, non-organic sleep disorders and other behavioural 
syndromes associated with physiological disturbances and physical 
factors, disorders of adult personality and behaviour, disorders of 
psychological development, behavioural and emotional disorders 
with onset in childhood and adolescence and unspecified mental 
disorders 
F34-F69, 
F80-F99 
293.8, 
296.8, 296.9,  
298.1, 298.2, 
299.0-301.9, 
302.1-302.9, 
305.9, 
306.0-309.9, 
312.0-315.9 
316 
a Further details on these codes can be found on the ICD-10 website [17].  
b Further details on these codes can be found in the ICD-9 book [18].  
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Table S2: OPCS-4 codes used to identify coronary revascularisation procedures 
  
Procedure 
type 
OPCS-4 
code 
Definition 
Coronary 
artery bypass 
graft 
K40 Saphenous vein graft replacement of coronary artery 
K41 Other autograft replacement of coronary artery 
K42 Allograft replacement of coronary artery 
K43 Prosthetic replacement of coronary artery 
K44 Other replacement of coronary artery 
K45 Connection of thoracic artery to coronary artery 
K46 Other bypass of coronary artery 
Percutaneous 
transluminal 
coronary 
angioplasty 
K49 Transluminal balloon angioplasty of coronary artery 
K50.1 Percutaneous transluminal laser coronary angioplasty 
K50.8 Other specified other therapeutic transluminal operations on coronary artery
1 
Percutaneous 
coronary 
intervention 
K75 Percutaneous transluminal balloon angioplasty and insertion of stent into 
coronary artery 
1. Glasgow Western Infirmary pre April 2002 only, as per National Statistics publications that report 
revascularisation procedures in Scotland [19]. 
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Text S1: Carstairs Index  
The Carstairs Index is based on four census variables (car ownership, male unemployment, 
household overcrowding and low occupational social class) [21]. It is calculated at the postcode 
sector level, where each postcode sector includes approximately 5,000 people and divided into 
quintiles based on the entire Scottish population [21]. The 2011 Carstairs Index defined the four 
variables as follows [21]: 
 No car ownership: the number of people living in private households without a car divided 
by the total number of people living in private households. 
 Male unemployment: the number of economically active males seeking or waiting to start 
work divided by the total number of all economically active males. 
 Overcrowding: the number of people living in private households with more than one 
person per room divided by the total number of people living in private households. 
 Low social class: the number of people living in private households where the household 
reference person (defined on the basis of working pattern, e.g. full-time or part-time, and 
age [22]) is economically active and in a low social class based on their occupation divided by 
the total number of people living in private households with an economically active 
household reference person. 
Earlier versions of the Carstairs Index used broadly similar definitions of the four variables, with 
some differences in how overcrowding and low social class were defined between the versions [21]. 
The Carstairs Index for each postcode sector is calculated by standardizing each of the four variables 
by its Scotland wide mean and standard deviation, and then summing the four standardized values 
[21]. 
Following recommendations for the analysis of deprivation in Scotland [20], we used the following 
releases of the Carstairs Index, according to the date of the incident myocardial infarction. 
Table: Recommended Carstairs Index release by date of incident myocardial infarction 
Date of incident myocardial infarction Carstairs Index release 
1991 – 1996 1991 
1997 – 2006 2001 
2007 - 2014 2011 
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Table S3: ICD-9 and ICD-10 codes used to identify alcohol use disorder 
  
ICD-10 Code  Description ICD-9 Code Description 
Mental & behavioural disorders due to use of alcohol  
F10.1 
F10.2 
F10.3  
F10.4 
F10.6 
Harmful use 
Dependence syndrome 
Withdrawal state 
Withdrawal state with delirium 
Amnesic syndrome 
291.0 
291.1 
291.2 
291.5 
303 
Delirium tremens 
Korsakov's psychosis, alcoholic 
Other alcoholic dementia 
Alcoholic jealousy 
Alcohol dependence syndrome 
Alcoholic liver disease  
K70.0 
K70.1 
K70.2 
K70.3 
K70.4 
K70.9 
Alcoholic fatty liver 
Alcoholic hepatitis 
Alcoholic fibrosis and sclerosis of liver 
Alcoholic cirrhosis of liver 
Alcoholic hepatic failure 
Alcoholic liver disease, unspecified 
571.0 
571.1 
571.2 
571.3 
Alcoholic fatty liver 
Acute alcoholic hepatitis 
Alcoholic cirrhosis of liver 
Alcoholic liver damage, unspecified 
Other conditions 
E24.4  Alcohol induced Pseudo-Cushing’s syndrome   No equivalent code in ICD-9 
E51.2  Wernicke’s Encephalopathy   No equivalent code in ICD-9 
G31.2  Degeneration of nervous system due to alcohol   No equivalent alcohol-specific code included in ICD-9 
G62.1  Alcoholic polyneuropathy 357.5 Alcoholic polyneuropathy 
G72.1  Alcoholic myopathy   No equivalent alcohol-specific code included in ICD-9 
I42.6  Alcoholic cardiomyopathy 425.5 Alcoholic cardiomyopathy 
K29.2  Alcoholic gastritis 535.3 Alcoholic gastritis 
K85.2 Alcohol-induced acute pancreatitis  No equivalent alcohol-specific code included in ICD-9 
K86.0  Alcohol-induced chronic pancreatitis   No equivalent alcohol-specific code included in ICD-9 
O35.4  Maternal care for (suspected) damage to foetus from alcohol   No equivalent alcohol-specific code included in ICD-9 
Y57.3  
Drugs, medicaments and biological substances causing adverse effects 
in therapeutic use: alcohol deterrents 
E947.3 
Drugs, medicaments and biological substances causing adverse 
effects in therapeutic use: alcohol deterrents 
Z50.2  Alcohol rehabilitation   No equivalent alcohol-specific code included in ICD-9 
Z71.4  Alcohol abuse counselling and surveillance   No equivalent alcohol-specific code included in ICD-9 
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Table S4: ICD codes used to identify comorbidities recorded during the incident MI admission 
 
Comorbidity
 ICD10 codes 
(first 3 digits) 
ICD9 codes 
(first 3 digits) 
Diabetes E10-14 250 
Chronic obstructive pulmonary disease J40-J44 490-492, 496 
Heart failure I50 428 
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Figure S1: Flow diagram for establishing the cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Including other psychoses, other mood disorders, disorders of adult personality and behaviour, eating 
disorders, neuroses, dissociative and somatoform disorders, behavioural and emotional disorders with onset 
in childhood and adolescence, non-organic sleep disorders, disorders of psychosocial development and 
unspecified mental disorders. 
2. Restricted cohort for the analysis of 5-year mortality. 
3. Restricted cohort for the analysis of time to further event outcomes.  
SMR01 records for adults 
(1991-2014) 
251 926 individuals 
with at least one MI 
243 091 individuals 
with a first MI 
242 665 individuals 
with valid data 
426 individuals with a mismatch between their 
SMR01 and death records 
8835 individuals with an MI recorded in the 
previous 10 years 
1736 individuals with missing data for area-based deprivation, 
urbanity or health board 
235 310 individuals  
in the cohort 
188 930 individuals who survived 
more than 30 days
3 
5619 individuals with a history of another 
mental health condition
1 
237 046 individuals with no history of a mental health condition or with a 
history of schizophrenia, bipolar disorder, depression 
226 537 individuals with first MI 
between 1991 and 2013
2 
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Table S5: Number of individuals and events per group 
 
Outcome 
No mental 
health admission 
Schizophrenia 
Bipolar 
disorder 
Depression Total 
Complete cases 227 506 923 642 6239 235 310 
  30-day mortality 44 580 (19.6%) 203 (22.0%) 154 (24.0%) 1443 (23.1%) 46 380 (19.7%) 
  1-year mortality 66 977 (29.4%) 309 (33.5%) 247 (38.5%) 2306 (37.0%) 69 839 (29.7%) 
  Mortality during follow-up 160 716 (70.6%) 684 (74.1%) 487 (75.9%) 4658 (74.7%) 166 545 (70.8%) 
  Revascularisation within 30 days 37 375 (16.4%) 137 (14.8%) 94 (14.6%) 1036 (16.6%) 38 642 (16.4%) 
  Revascularisation within 90 days 41490 (18.2%) 142 (15.4%) 104 (16.2%) 1126 (18.0%) 42862 (18.2%) 
Complete cases 
(MI admissions up to 2013) 
219 161 868 611 5897 226 537 
  5-year mortality 100 560 (45.9%) 457 (52.6%) 350 (57.3%) 3388 (57.5%) 104 755 (46.2%) 
Complete cases 
(individuals who survived 
 more than 30 days) 
182 926 720 488 4796 188 930 
   Time to further MI 53 376 (29.2%) 205 (28.5%) 139 (28.5%) 1496 (31.2%) 55 216 (29.2%) 
   Time to further vascular event 65 857 (36.0%) 248 (34.4%) 176 (36.1%) 1845 (38.5%) 68 126 (36.1%) 
 
  
 
8 
 
Table S6: Number of individuals and events per group – sensitivity analysis (depression based on 
psychiatric hospital admission records only) 
 
Outcome 
No mental 
health admission 
Schizophrenia 
Bipolar 
disorder 
Depression Total 
Complete cases 230 048 923 642 3111 234 724 
    30-day mortality 45 249 (19.7%) 203 (22.0%) 154 (24.0%) 663 (21.3%) 46 269 (19.7%) 
    1-year mortality 68 044 (29.6%) 309 (33.5%) 247 (38.5%) 1033 (33.2%) 69 633 (29.7%) 
    Mortality during follow-up 162 709 (70.7%) 684 (74.1%) 487 (75.9%) 2259 (72.6%) 166 139 (70.8%) 
   Revascularisation within 30 days 37 741 (16.4%) 137 (14.8%) 94 (14.6%) 548 (17.6%) 38 520 (16.4%) 
   Revascularisation within 90 days 41 893 (18.2%) 142 (15.4%) 104 (16.2%) 599 (19.3%) 42 738 (18.2%) 
Complete cases 
(MI admissions up to 2013) 
221 553 868 611 2958 225 990 
    5-year mortality 102 103 (46.1%) 457 (52.6%) 350 (57.3%) 1544 (52.2%) 104 454 (46.2%) 
Complete cases 
(individuals who survived  
more than 30 days) 
184 799 720 488 2448 188 455 
   Time to further MI 53 970 (29.2%) 205 (28.5%) 139 (28.5%) 756 (30.9%) 55 070 (29.2%) 
   Time to further vascular event 66 593 (36.0%) 248 (34.4%) 176 (36.1%) 939 (38.4%) 67 956 (36.1%) 
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Table S7: Sensitivity analysis for models 1 and 2 (depression based on psychiatric hospital admission records only) 
For each outcome, this table presents a summary of the results for models 1 and 2, along with a summary of the results of the sensitivity analysis for models 1 and 2. In the sensitivity 
analysis, depression is only identified using psychiatric hospital admission records (SMR04). Thus fewer people are included in the depression group, and the overall cohort is smaller. The 
results for schizophrenia and bipolar disorder differ slightly between the main analysis and the sensitivity analysis because the comparison group has changed (some people who were 
included in the depression group for the main analysis are included in the no mental health admission group for the sensitivity analysis). 
Outcome Model N Schizophrenia Bipolar disorder Depression 
30-day mortality, 
OR (95% CI) 
Model 1 235 310 2.06 (1.74, 2.44) 1.58 (1.30, 1.91) 1.37 (1.29, 1.46) 
Model 1 (depression – SMR04 only) 234 724 2.05 (1.73, 2.43) 1.57 (1.29, 1.90) 1.36 (1.24, 1.49) 
Model 2 235 310 1.95 (1.64, 2.30) 1.53 (1.26, 1.86) 1.31 (1.23, 1.40) 
Model 2 (depression – SMR04 only) 234 724 1.94 (1.63, 2.29) 1.52 (1.25, 1.84) 1.27 (1.16, 1.40) 
1-year mortality, 
OR (95% CI) 
Model 1 235 310 2.41 (2.07, 2.81) 1.99 (1.66, 2.37) 1.65 (1.55, 1.75) 
Model 1 (depression – SMR04 only) 234 724 2.40 (2.05, 2.79) 1.97 (1.65, 2.35) 1.54 (1.42, 1.68) 
Model 2 235 310 2.22 (1.91, 2.59) 1.90 (1.59, 2.27) 1.53 (1.45, 1.63) 
Model 2 (depression – SMR04 only) 234 724 2.20 (1.89, 2.56) 1.88 (1.57, 2.25) 1.40 (1.29, 1.52) 
5-year mortality, 
OR (95% CI) 
Model 1 226 537
a 
3.11 (2.67, 3.63) 2.28 (1.89, 2.75) 2.08 (1.96, 2.22) 
Model 1 (depression – SMR04 only) 225 990
a 
3.08 (2.64, 3.59) 2.26 (1.87, 2.72) 1.84 (1.69, 2.01) 
Model 2 226 537
 a
 2.75 (2.35, 3.20) 2.15 (1.78, 2.59) 1.82 (1.71, 1.94) 
Model 2 (depression – SMR04 only) 225 990
 a
 2.70 (2.32, 3.15) 2.12 (1.76, 2.55) 1.55 (1.43, 1.69) 
Mortality during 
follow-up, HR (95% 
CI) 
Model 1 235 310 1.97 (1.82, 2.12) 1.63 (1.50, 1.79) 1.44 (1.40, 1.49) 
Model 1 (depression – SMR04 only) 234 724 1.96 (1.82, 2.11) 1.63 (1.49, 1.78) 1.40 (1.34, 1.46) 
Model 2 235 310 1.82 (1.68, 1.96) 1.55 (1.42, 1.70) 1.35 (1.31, 1.39) 
Model 2 (depression – SMR04 only) 234 724 1.80 (1.67, 1.94) 1.54 (1.41, 1.68) 1.27 (1.22, 1.32) 
Time to further MI,  
HR (95% CI) 
Model 1 188 930
b 
1.50 (1.31, 1.72) 1.38 (1.17, 1.63) 1.45 (1.38, 1.53) 
Model 1 (depression – SMR04 only) 188 455
 b
 1.50 (1.30, 1.72) 1.38 (1.16, 1.63) 1.38 (1.29, 1.49) 
Model 2 188 930
 b
 1.42 (1.24, 1.63) 1.34 (1.13, 1.58) 1.38 (1.31, 1.45) 
Model 2 (depression – SMR04 only) 188 455
 b
 1.41 (1.23, 1.62) 1.33 (1.12, 1.57) 1.29 (1.20, 1.39) 
Time to further MI 
or stroke 
HR (95% CI) 
Model 1 188 930
 b 
1.55 (1.37, 1.75) 1.45 (1.25, 1.68) 1.48 (1.41, 1.55) 
Model 1 (depression – SMR04 only) 188 455
 b
 1.54 (1.36, 1.75) 1.44 (1.24, 1.67) 1.42 (1.33, 1.51) 
Model 2 188 930
 b
 1.46 (1.29, 1.65) 1.40 (1.20, 1.62) 1.40 (1.33, 1.46) 
Model 2 (depression – SMR04 only) 188 455
 b
 1.45 (1.28, 1.64) 1.39 (1.19, 1.61) 1.31 (1.23, 1.40) 
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Outcome Model N Schizophrenia Bipolar disorder Depression 
Revascularisation 
within 30 days, HR 
(95% CI) 
Model 1 235 310
 
0.52 (0.44, 0.62) 0.66 (0.54, 0.80) 0.71 (0.67, 0.76) 
Model 1 (depression – SMR04 only) 234 724 0.53 (0.45, 0.62) 0.66 (0.54, 0.81) 0.81 (0.75, 0.88) 
Model 2 235 310 0.57 (0.48, 0.67) 0.69 (0.56, 0.85) 0.78 (0.73, 0.83) 
Model 2 (depression – SMR04 only) 234 724 0.58 (0.49, 0.68) 0.70 (0.57, 0.85) 0.90 (0.82, 0.98) 
Revascularisation 
within 90 days, HR 
(95% CI) 
Model 1 235 310
 
0.49 (0.42, 0.58) 0.66 (0.54, 0.80) 0.70 (0.66, 0.75) 
Model 1 (depression – SMR04 only) 234 724 0.49 (0.42, 0.58) 0.66 (0.55, 0.81) 0.81 (0.74, 0.87) 
Model 2 235 310 0.53 (0.45, 0.63) 0.69 (0.57, 0.84) 0.77 (0.73, 0.82) 
Model 2 (depression – SMR04 only) 234 724 0.54 (0.46, 0.63) 0.70 (0.58, 0.85) 0.89 (0.82, 0.97) 
Model 1 is adjusted for age at MI, sex and year of MI. Model 2 is adjusted for age at MI, sex, year of MI, history of alcohol use disorder, deprivation, urbanity and health board. In the 
sensitivity analysis, depression is only identified using mental health hospital admission records (SMR04).  
HR=Hazard ratio. OR=Odds ratio.  
a Stroke admissions up to 2013 in order to ensure that all individuals have at least 5 years’ follow-up.  
b Individuals who survived more than 30 days after MI. 
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Table S8: P-values for analysis of deviance comparing models without each interaction to the 
model including all three interactions 
  
  
Interaction 
Outcome  Model SMI: age at MI SMI: year of MI SMI: sex 
30-day mortality 
  
Model 3 <0.0001 0.64 0.19 
Model 3 (depression - SMR04 only) 0.0029 0.65 0.59 
1-year mortality Model 3 0.00014 0.18 0.38 
Model 3 (depression - SMR04 only) 0.0037 0.58 0.63 
5-year mortality 
  
Model 3 0.15 0.59 0.30 
Model 3 (depression - SMR04 only) 0.28 0.83 0.24 
Mortality during 
follow-up 
Model 3 <0.0001 <0.0001 0.094 
Model 3 (depression - SMR04 only) <0.0001 0.12 0.077 
Time to further 
myocardial infarction  
Model 3 0.87 0.16 0.25 
Model 3 (depression - SMR04 only) 0.78 0.45 0.27 
Time to further 
vascular event 
Model 3 0.31 0.018 0.29 
Model 3 (depression - SMR04 only) 0.29 0.29 0.19 
Revascularisation 
within 30 days 
  
Model 3 <0.0001 0.19 0.00031 
Model 3 (depression - SMR04 only) 0.00032 0.31 0.00063 
Revascularisation 
within 90 days 
  
Model 3 <0.0001 0.062 <0.0001 
Model 3 (depression - SMR04 only) 0.00017 0.33 0.00012 
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Figure S2: Odds ratios for 5-year mortality comparing people with a hospital record for each 
SMI versus no record of any mental health condition 
Sex-specific odds ratios and 95% confidence intervals for 5-year mortality following a myocardial infarction, among 
70-year olds, comparing people with a prior hospital record for each SMI versus no prior record of any mental health 
condition, 1991 – 2013. Estimates were obtained from a logistic regression model adjusting for age at MI, year of 
MI, sex, deprivation, urbanity, health board and history of an alcohol use disorder, and including interactions 
between SMI and each of age at MI, year of MI and sex. Shading represents 95% confidence intervals.  
  
 
13 
 
Figure S3: Hazard ratios for mortality during follow-up comparing people with a hospital 
record for each SMI versus no record of any mental health condition 
Sex-specific hazard ratios and 95% confidence intervals for morality during follow-up after a myocardial infarction, 
among 70-year olds, comparing people with a prior hospital record for each SMI versus no prior record of any 
mental health condition, 1991 – 2014. Estimates were obtained from a Cox proportional hazards model adjusting for 
age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol use disorder, and including 
interactions between mental health condition and each of age at MI, year of MI and sex. Shading represents 95% 
confidence intervals. 
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Figure S4: Hazard ratios for time to further myocardial infarction comparing people with a 
hospital record for each SMI versus no record of any mental health condition  
Sex-specific hazard ratios and 95% confidence intervals for time to further myocardial infarction following first 
myocardial infarction, among 70-year olds, comparing people with a hospital record for each SMI versus no record 
of any mental health condition, 1991 - 2014. Estimates were obtained from a Cox proportional hazards model 
adjusting for age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol use disorder, 
and including interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95% 
confidence intervals. 
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Figure S5: Hazard ratios for time to further vascular event (MI or stroke) comparing people 
with a hospital record for each SMI versus no record of any mental health condition  
Sex-specific hazard ratios and 95% confidence intervals for time to further vascular event (MI or stroke) following 
first myocardial infarction, among 70-year olds, comparing people with a hospital record for each SMI versus no 
record of any mental health condition, 1991 to 2014. Estimates were obtained from a Cox proportional hazards 
model adjusting for age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol use 
disorder, and including interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95% 
confidence intervals. 
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Figure S6: Hazard ratios for revascularisation within 90 days comparing people with a hospital 
record for each SMI versus no record of any mental health condition  
Sex-specific hazard ratios and 95% confidence intervals for revascularisation within 90 days following a myocardial 
infarction, among 70-year olds, comparing people with a hospital record for each SMI versus no record of any 
mental health condition, 1991 - 2014. Estimates were obtained from a Cox proportional hazards model adjusting for 
age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol use disorder, and including 
interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95% confidence intervals. 
 
 
